Racial And Ethnic Disparities In The Contemporary Utilization Of Left Ventricular Assist Devices In The United States
Jose Lopez,Gustavo Duarte,Justin Mark,Bryan Vallejo,Robert Chait,Sajid Mirza,Nasrien Ibrahim
DOI: https://doi.org/10.1016/j.cardfail.2023.10.424
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Introduction Left ventricular assist devices (LVADs) are indicated for patients with Stage D heart failure with reduced ejection fraction (HFrEF). Furthermore, stage D HFrEF is associated with increased hospital admissions. Racial and ethnic disparities in the access LVADs have been described in the past, revealing significant gaps in care. However, it remains to be seen if current efforts to mitigate health disparities have improved access to LVADs in underrepresented populations. Therefore, we aim to clarify existing practices in the United States to examine if there have been any changes in racial disparities in the access to LVADs and use this critical knowledge to direct additional steps to mitigate health disparities. Hypothesis Racial disparities exist in the access to LVADs in the US. Methods The National Inpatient Sample (NIS) was queried from 2016 to 2019 to identify all adult admissions with HFrEF who underwent LVAD placement using the International Classification of Diseases Tenth Revision (ICD-10) codes. We stratified the sample into 3 study groups: Black, Hispanic, and White. We explored baseline characteristics, LVAD utilization (defined as the number of LVADs per 100,000 admissions with a history of HFrEF) and completed a multivariate regression analysis to assess the association of race and ethnicity with LVAD placement and clinically meaningful outcomes. Results A total of 7,674,108 admissions with HFrEF were included study, and 14,665 (0.2%) underwent LVAD placement. Seventy-seven percent of patients who received an LVAD were male. Black patients were likelier to be of lower socioeconomic status and be enrolled in Medicaid than Hispanic and White patients. LVAD utilization was higher in Black patients compared to White and Hispanic patients (256 vs. 175 vs. 175, respectively, p<0.001). Compared to White race, Black race had higher odds of receiving an LVAD (OR=1.60, 95% CI 1.41-1.80, p<0.001), receiving a blood transfusion (OR=1.40, 95% CI 1.05-1.84, p=0.02), and non-routine discharge (OR=1.35, 95% CI 1.09-1.67, p=0.006). Hispanic race was associated with lower odds of survival free of stroke (OR=0.68, 0.47-0.98, p=0.038) compared to White race. However, there was no difference in mortality between the study groups. Conclusion Black race was associated with higher odds of LVAD utilization after adjusting for multiple confounders. Compared to previous studies, inequalities in outcomes remain while an apparent disparity in the access to LVADs in Black patients is not evident in this study which might be related to potential confounders or other factors. Further studies evaluating both outcomes are needed to clarify the reasons behind these findings.
cardiac & cardiovascular systems